PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10412944-3	1999	We studied the effect of BSO in rats bearing intrahepatically implanted tumors of the CC531 colorectal cancer cell line on the antitumor activity of melphalan (L-PAM).	Melphalan	149-158	peptidylglycine alpha-amidating monooxygenase	Rattus norvegicus	162-165	
7092953-1	1982	The pharmacokinetics and macromolecular interactions of [14C-ring]melphalan (L-PAM) in blood were studied in rats following a single oral dose (20 mg/kg, 0.1 mCi/kg).	Melphalan	66-75	peptidylglycine alpha-amidating monooxygenase	Rattus norvegicus	79-82	
27685524-6	2016	MATERIALS AND METHODS: Melphalan (L-PAM) injected i.v.	Melphalan	23-32	peptidylglycine alpha-amidating monooxygenase	Rattus norvegicus	36-39	
24980763-2	2014	The aim of the study was to evaluate the myeloprotective possibilities of carbon enterosorbents in the case of usage of alkilating drug melphalan (L-PAM).	Melphalan	136-145	peptidylglycine alpha-amidating monooxygenase	Rattus norvegicus	149-152